Research team confirms safety of Alzheimer's drug Lecanemab
World 17:27 25/03/2026TOKYO -- More than 90 pct of patients receiving Lecanemab, an Alzheimer's drug, in hospitals across Japan have been able to continue treatment without strong side effects, a group of researchers in the country said.
Japan starts final-stage trial for iPS drug for Alzheimer's
World 12:40 04/06/2025KYOTO -- A Japanese team said Tuesday that it has started a final-stage clinical trial to administer to patients with familial Alzheimer's disease a drug discovered through induced pluripotent stem, or iPS, cells.